Questions? Call 800-624-6242
add to cart
Rights & Permissions
. "Appendix B: Open Meeting Agendas." Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military. Washington, DC: The National Academies Press, 2002.
Please select a format:
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Biologic Warfare Defense Research and Endemic Infectious Diseases
Research: Whence and why the dichotomy
COL John F. Glenn, Ph.D.
Deputy for Research and Development
U.S. Army Medical Research and Materiel Command
Discussion with Sponsor:
Overview of the challenges to adequate vaccine strategy presented by industry and DoD policies and constraints
Overview of the regulatory parameters that currently affect military vaccine strategy
Discussion of what the U.S. Army seeks to gain from this committee report
Discussion of charge
Break, end of open session
June 19 and 20, 2000
The Foundry Building, Washington, D.C.
19 June 2000
Welcome and Introduction
Stanley Lemon, M.D., Chair
Examples of the Impact of Vaccine Preventable Infectious Disease:
Impact of Recent Adenovirus Outbreaks in Military Training Centers
CAPT Gregory Gray, M.D., M.P.H.
Director, DoD Center for Deployment Health Research
Naval Health Research Center, San Diego
Lt Col James Neville, M.D., M.P.H.
Chief, Force Health Protection and Surveillance Branch
U.S. Air Force Institute for Environment, Safety & Occupational
Health Risk Analysis
Brooks Air Force Base